Samsung Bioepis and Biogen have announced that the European Commission (EC) has approved Opuviz 40 m...
read moreAldeyra Therapeutics has announced a major milestone as the FDA formally accepted its resubmitted Ne...
read moreThe Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking co...
read moreA groundbreaking study from the University of Colorado Anschutz Medical Campus has identified a sign...
read moreEyenovia has announced that its Phase 3 CHAPERONE study, aimed at treating pediatric progressive myo...
read moreSun Pharmaceutical has shared new Phase 4 clinical trial data, showcasing the efficacy of Cequa (cyc...
read moreIn the largest genetic study on cataracts to date, researchers from QIMR Berghofer Medical Research ...
read moreThrough its exclusive recycling initiatives, Bausch + Lomb has collected 94,119,275 units of used co...
read moreMediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a...
read moreIn a groundbreaking achievement, researchers from Osaka University in Japan have successfully conduc...
read more